Sun Pharma to buy Israel's Taro Pharma
Monday, May 21, 2007Sun Pharmaceutical Industries has signed definitive agreements to acquire Israel's Taro Pharmaceutical Industries, for an all-cash deal of $454 million. The acquisition will be funded through internal accruals and proceeds from its earlier $350 million FCCB.
Taro Pharmaceutical is a multinational generic manufacturer with established subsidiaries, manufacturing and products across the U.S., Israel, Canada. North America represents more than 90% of Taro's sates.
Recent Corporate Earnings / Breaking News
- HDFC Bank to raise Rs 4200 crore
- Usha Martin dividend, stock-split; Orient Paper ri...
- Alfa Laval, Dena Bank Move Up
- Texmaco Limited - ABN Trading Call
- Punj Lloyd, IVRCL Infra Bag Orders
- Bharat Seats - Bonus. Jet Airways -Rights Issue
- Goldman Sachs raises stake in Indiabulls
- NTPC inks JV with SCCL
- Sobha Developers township project in Kerala
- Buy-back rumors keep Castrol India hot
